Bentofighter
2021-10-27
Pls like
After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
5
6
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":852527553,"tweetId":"852527553","gmtCreate":1635292708192,"gmtModify":1635292708603,"author":{"id":3583478720415511,"idStr":"3583478720415511","authorId":3583478720415511,"authorIdStr":"3583478720415511","name":"Bentofighter","avatar":"https://static.tigerbbs.com/3d3b444e1397cd8d1ec1b18c5c8c5db5","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":31,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Pls like</p></body></html>","htmlText":"<html><head></head><body><p>Pls like</p></body></html>","text":"Pls like","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/852527553","repostId":2178288807,"repostType":4,"repost":{"id":"2178288807","kind":"news","pubTimestamp":1635291594,"share":"https://www.laohu8.com/m/news/2178288807?lang=&edition=full","pubTime":"2021-10-27 07:39","market":"us","language":"en","title":"After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2178288807","media":"StreetInsider","summary":"Cortexyme, Inc. 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat , an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis . The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and","content":"<p>After-Hours Stock Movers:</p>\n<p>Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.</p>\n<p>Tenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.</p>\n<p>Juniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.</p>\n<p>QuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).</p>\n<p>F5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.</p>\n<p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.</p>\n<p>Microsoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.</p>\n<p>Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Cortexyme,Tenable,QuantumScape,Juniper Networks and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 07:39 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=19109726><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19109726\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWTR":"Twitter","HOOD":"Robinhood","JNPR":"瞻博网络","TENB":"Tenable Holdings Inc.","QNETCN":"纳斯达克中美互联网老虎指数"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19109726","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178288807","content_text":"After-Hours Stock Movers:\nCortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of atuzaginstat (COR388), an investigational orally administered small-molecule that targets gingipain proteases from the bacterium Porphyromonas gingivalis (P. gingivalis). The 643-participant study in mild to moderate patients with Alzheimers disease did not meet statistical significance in its co-primary cognitive and functional endpoints as measured by ADAS-Cog11 and ADCS-ADL at end of the treatment period in the overall cohort.\nTenable Holdings, Inc. (NASDAQ: TENB) 10% HIGHER; reported Q3 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $138.74 million versus the consensus estimate of $134.53 million.\nJuniper Networks (NYSE: JNPR) 4.6% HIGHER; reported Q3 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.2 billion. Juniper Networks sees Q4 2021 EPS of $0.48-$0.58, versus the consensus of $0.53. Juniper Networks sees Q4 2021 revenue of $1.215-1.315 billion, versus the consensus of $1.27 billion.\nQuantumScape (NYSE: QS) 4.7% LOWER; reported Q3 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10).\nF5 Networks (NASDAQ: FFIV) 4.5% HIGHER; reported Q4 EPS of $3.01, $0.26 better than the analyst estimate of $2.75. Revenue for the quarter came in at $682 million versus the consensus estimate of $672.2 million. F5 Networks sees Q1 2022 EPS of $2.71-$2.83, versus the consensus of $2.76. F5 Networks sees Q1 2022 revenue of $665-685 million, versus the consensus of $667.23 million.\nTwitter (NYSE: TWTR) 3.1% HIGHER; reported Q3 EPS of ($0.54), $0.71 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.28 billion. Twitter sees Q4 2021 revenue of $1.5-1.6 billion, versus the consensus of $1.58 billion.\nMicrosoft (NASDAQ: MSFT) 1.9% HIGHER; reported Q1 EPS of $2.71, $0.64 better than the analyst estimate of $2.07. Revenue for the quarter came in at $45.3 billion versus the consensus estimate of $43.97 billion. Guides Q2 revenue above the Street.\nAlphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.7% LOWER; reported Q3 EPS of $27.99, $4.52 better than the analyst estimate of $23.47. Revenue for the quarter came in at $65.12 billion versus the consensus estimate of $63.45 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/852527553"}
精彩评论